KLRS
Financials
- Market Capitalization 108.25 M
- Employee 20
- Founded 2019
- CEO N/A
- Website www.kalaristx.com
- Headquarter Delaware, United States
- FIGI BBG00P80SH34
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3942 |  ONCY Oncolytics Biotech Inc. - Common Stock | 0.91 USD | -2.15% | +7.06% | +3.41% | -20.18% | 108.61 M USD | ||
| 3943 |  ANIX Anixa Biosciences, Inc. - Common Stock | 3.19 USD | +4.25% | +7.77% | +23.64% | -0.93% | 108.53 M USD | ||
| 3955 |  BDTX Black Diamond Therapeutics, Inc. - Common Stock | 1.86 USD | -2.11% | -8.82% | +7.51% | -36.95% | 106.58 M USD | ||
| 3958 |  ICCC ImmuCell Corporation - Common Stock | 11.72 USD | +5.78% | +11.73% | +23.11% | +84.86% | 106.03 M USD |
Frequently asked questions about Kalaris Therapeutics, Inc. - Common Stock
What is the Kalaris Therapeutics, Inc. - Common Stock stock price today?
The current price of Kalaris Therapeutics, Inc. - Common Stock (KLRS) is 4.55. Over the past 24 hours, the stock has changed by +2.94%. Follow the KLRS chart for real-time price dynamics.
What is the stock ticker of Kalaris Therapeutics, Inc. - Common Stock?
Kalaris Therapeutics, Inc. - Common Stock trades under the ticker KLRS. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Kalaris Therapeutics, Inc. - Common Stock stock going up?
KLRS has changed by -6.76% over the last week, +3.41% over the last month, and -55.52% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Kalaris Therapeutics, Inc. - Common Stock net income for the last quarter?
Kalaris Therapeutics, Inc. - Common Stock reported net income of -10.86 M for the last quarter. The previous quarter showed -10 M, which means net income changed by -8.58%.
How many employees does Kalaris Therapeutics, Inc. - Common Stock have?
As of the latest available data, Kalaris Therapeutics, Inc. - Common Stock has 20 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Kalaris Therapeutics, Inc. - Common Stock stock?
You can buy Kalaris Therapeutics, Inc. - Common Stock (KLRS) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Kalaris Therapeutics, Inc. - Common Stock stock?
Investing in Kalaris Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the KLRS chart and related analysis on metatrader.com as part of your research.